RLAY logo

Relay Therapeutics (RLAY)

Profile

Full Name

Relay Therapeutics, Inc.

Ticker Symbol

RLAY

Exchange

NASDAQ

Country

United States

IPO

July 16, 2020

Indexes

Not included

Employees

261

Key Details

Price

$2.61(-5.43%)

Market cap

$442.45M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$10.01M(-60.83% YoY)

Annual EPS

-$2.36(+15.41% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 7, 25 HC Wainwright & Co.
Buy
Feb 27, 25 Stifel
Buy
Feb 27, 25 Goldman Sachs
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Dec 12, 24 JMP Securities
Market Outperform
Dec 5, 24 Leerink Partners
Outperform
Dec 4, 24 Leerink Partners
Outperform
Dec 4, 24 HC Wainwright & Co.
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 14, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Relay Therapeutics?
  • Does Relay Therapeutics pay dividends?
  • What sector is Relay Therapeutics in?
  • What industry is Relay Therapeutics in?
  • What country is Relay Therapeutics based in?
  • When did Relay Therapeutics go public?
  • Is Relay Therapeutics in the S&P 500?
  • Is Relay Therapeutics in the NASDAQ 100?
  • Is Relay Therapeutics in the Dow Jones?
  • When was Relay Therapeutics's last earnings report?
  • When does Relay Therapeutics report earnings?
  • Should I buy Relay Therapeutics stock now?

What is the ticker symbol for Relay Therapeutics?

The ticker symbol for Relay Therapeutics is NASDAQ:RLAY

Does Relay Therapeutics pay dividends?

No, Relay Therapeutics does not pay dividends

What sector is Relay Therapeutics in?

Relay Therapeutics is in the Healthcare sector

What industry is Relay Therapeutics in?

Relay Therapeutics is in the Biotechnology industry

What country is Relay Therapeutics based in?

Relay Therapeutics is headquartered in United States

When did Relay Therapeutics go public?

Relay Therapeutics's initial public offering (IPO) was on July 16, 2020

Is Relay Therapeutics in the S&P 500?

No, Relay Therapeutics is not included in the S&P 500 index

Is Relay Therapeutics in the NASDAQ 100?

No, Relay Therapeutics is not included in the NASDAQ 100 index

Is Relay Therapeutics in the Dow Jones?

No, Relay Therapeutics is not included in the Dow Jones index

When was Relay Therapeutics's last earnings report?

Relay Therapeutics's most recent earnings report was on Feb 26, 2025

When does Relay Therapeutics report earnings?

The next expected earnings date for Relay Therapeutics is May 2, 2025

Should I buy Relay Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page